Select for export Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.06.6.30 Copy citation Copy BibTeX Psychiatric News 2022-05-22 Richard Karel OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2066650 PubMed 35426754 Copy citation Copy BibTeX Expert Opinion on Drug Safety 2022-04-26 Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Randomized Controlled Trial More
Select for export Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/molecules27082520 PubMed 35458717 Copy citation Copy BibTeX Unknown journal 2022-04-13 Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221084063 PubMed 35388724 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-04-06 Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. Europe PMC Published psilocybin AnxietySpiritualityObservational Study Observational Study More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0264927 PubMed 35294453 Copy citation Copy BibTeX PLoS ONE 2022-03-15 Dworatzyk K, Jansen T, Schmidt TT. Europe PMC Published psilocybin AnxietyConsciousnessMystical Experience Observational Study More
Select for export The therapeutic potential of psilocybin: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2047929 PubMed 35225143 Copy citation Copy BibTeX Unknown journal 2022-03-01 van Amsterdam J, van den Brink W. Europe PMC Published psilocybin Clinical TrialRandomized Controlled TrialSystematic Review Randomized Controlled Trial More
Select for export Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211069100 PubMed 35107059 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2022-02-28 Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ PubMed Published psilocybin Review ArticleHealthcare WorkersSafety Review Article More
Select for export Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01297-2 PubMed 35217796 Copy citation Copy BibTeX Neuropsychopharmacology 2022-02-24 Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P Europe PMC Published psilocybin AnxietyPharmacologyHealthy Volunteers Clinical Trial More
Select for export The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jpainsymman.2022.01.024 PubMed 35157985 Copy citation Copy BibTeX Unknown journal 2022-02-10 Maia LO, Beaussant Y, Garcia ACM. Europe PMC Published psilocybin AnxietySpiritualityRandomized Controlled Trial Randomized Controlled Trial More
Select for export Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.21944 PubMed 35273885 Copy citation Copy BibTeX Unknown journal 2022-02-04 Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.749068 PubMed 35177979 Copy citation Copy BibTeX Unknown journal 2022-01-26 Markopoulos A, Inserra A, De Gregorio D, Gobbi G. Europe PMC Published psilocybin DepressionAnxietyNeuroplasticity Review Article More
Select for export Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06049-6 PubMed 35022823 Copy citation Copy BibTeX Unknown journal 2022-01-12 Bender D, Hellerstein DJ. Europe PMC Published psilocybin Brain ImagingAgingClinical Trial Clinical Trial More
Select for export The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211064720 PubMed 35090363 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-03 Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J Europe PMC Published psilocybin DepressionReceptor PharmacologyEmotional Processing Randomized Controlled Trial More
Select for export Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1076459 PubMed 36844032 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM PubMed Published psilocybin DepressionBrain ImagingMechanism of Action Review Article More
Select for export Predictors of Psychedelic Experience: A Thematic Analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/5d7fc Copy citation Copy BibTeX PsyArXiv 2021-12-20 McCartney A, McGovern H, De Foe A. PsyArXiv PREPRINT (not peer reviewed) psilocybin Mechanism of Action Other More
Select for export Predictors of Psychedelic Experience: A Thematic Analysis Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2021-12-20 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin Mechanism of Action Qualitative Study More
Select for export Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2021.12.14 Copy citation Copy BibTeX Psychiatric News 2021-11-28 David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman OpenAlex Published psilocybin DepressionAnxietyConsciousness Clinical Trial More
